FDA is adding a warning to Johnson & Johnson's coronavirus vaccine that rare blood clotting events might occur, primarily among women under age 50. Therefore, it was a shock when a report found that six women who received the J&J COVID-19 vaccine had developed cerebral venous sinus thrombosis (CVST) blood clots. By the time of the ACIP meeting on April 23, they were 15 cases of people who had CVST with thrombocytopenia after receiving the J&J vaccine. Additionally, there would be just with two expected of rare blood clots. Next, they compared what the effect of resuming the J&J vaccine would have based on age and sex.

Source: Daily Mail April 27, 2021 19:59 UTC